The product, named after the formulation’s “next-GENeration” features, is a 100% natural, water-dispersible curcumin ingredient.

Curcugen’s patent-pending composition base is a novel-source turmeric oleoresin, rather than the 95% standardized curcuminoid material that DTB claims is common in the supplement industry. The SELF D platform technology optimizes the oleoresin base. It also avoids the need to complement the curcuminoids with other, non-turmeric ingredients, or to reconstitute it with displaced turmeric ingredients.

DBT says that Curcugen’s unique formulation preserves the original complex of curcuminoids, essential oils, and polar resins within the optimized oleoresin matrix, helping to overcome the absorption issues characteristic of unformulated curcumin, which can optimize dispersion in beverage formats. 

According to DBT, additional unique properties include a self-dispersing mechanism in liquid that allows for a clinical dose in a fluid medium, making it suitable for functional foods and ready-to-mix/RTD beverages. As a free-flowing dry ingredient, Curcugen offers a number of formulation options, including traditional capsules, gummies, soft chews and oral dispersible formats, among others.

The product is claimed to be among the most concentrated curcumin ingredients on the market — with curcuminoid concentrates at a 50% standard — and maintains a 95% turmeric rhizome base, free from chemical excipients.

“We believe Curcugen’s comprehensive profile will generate significant interest and readily establish itself even in this, the most crowded of curcumin markets, since it overcomes a number of limitations including delivery, potency, bioavailability and clean-label appeal,” said Shavon Jackson-Michel, Director of Medical & Scientific Affairs at Dolcas Tenshi Bioceuticals.”

“Curcugen was developed using our patented SELF D platform technology,” said Somashekara Nirvanashetty, CEO and co-founder of Olene Life Sciences Pvt. Ltd. The company manufactures the Curcugen technology that enhances the natural, whole-food state of curcumin. “It is a truly ‘disruptive innovation’ sure to redefine the curcumin landscape, allowing Curcugen to emerge as one of the leading curcumin products globally.”

While the curcumin industry might appear saturated, DBT notes that recent evaluations of the market actually suggest an expanding market with the prospect of continued thriving growth of 5.5% per year, into at least 2024, according to research by Future Market Insights.

An extensive clinical study program for Curcugen evaluating safety and efficacy (including GRAS assessment) is being initiated both domestically and internationally. The results of several such studies are expected to be published by the end of this year.